Shedding light on new treatment options for perimenopausal depression and sleep problems

October 03, 2018

CLEVELAND, Ohio (October 3, 2018)--Light therapy has long been a recognized treatment option for depression. But can it help perimenopausal women struggling with depression and sleep problems as the result of hormone changes? A new study from the University of California suggests that it can by altering a woman's natural sleep/wake cycle. Preliminary study results will be presented during The North American Menopause Society (NAMS) Annual Meeting in San Diego, October 3-6, 2018.

Over the years, much has been learned about the benefits of sleep and light therapy. Numerous studies have documented the therapeutic value of total and partial wake therapy, as well as light therapy, in treating depressive disorders linked to women's reproductive menstrual cycles. Other studies have shown that sleep/wake cycles (technically known as melatonin circadian rhythms) are often phase-delayed (shifted later) in women with perimenopausal depression.

Putting the results of the various studies together, researchers in California hypothesized that depression and sleep quality could be improved in women with perimenopausal depression by phase-advancing (shifting earlier) circadian rhythms of melatonin in relation to the sleep/wake cycle. What they found was that through various sleep intervention and light therapy techniques they were able to significantly improve the mood scores of the study participants in as few as two weeks.

"This study demonstrates that women with perimenopausal depression and sleep issues may now have a non-pharmacological and non-hormonal option that may help with sleep and improve their mood," says Dr. Barbara Parry, lead author of the study from the University of California in San Diego.

"The results of this study will hopefully lead to additional research that will provide symptomatic women more options than were previously available," says Dr. JoAnn Pinkerton, NAMS executive director."

Drs. Parry and Pinkerton are available for interviews before the presentation at the Annual Meeting.
-end-
Founded in 1989, The North American Menopause Society (NAMS) is North America's leading nonprofit organization dedicated to promoting the health and quality of life of all women during midlife and beyond through an understanding of menopause and healthy aging. Its multidisciplinary membership of 2,000 leaders in the field--including clinical and basic science experts from medicine, nursing, sociology, psychology, nutrition, anthropology, epidemiology, pharmacy, and education--makes NAMS uniquely qualified to serve as the definitive resource for health professionals and the public for accurate, unbiased information about menopause and healthy aging. To learn more about NAMS, visit http://www.menopause.org.

The North American Menopause Society (NAMS)

Related Depression Articles from Brightsurf:

Children with social anxiety, maternal history of depression more likely to develop depression
Although researchers have known for decades that depression runs in families, new research from Binghamton University, State University of New York, suggests that children suffering from social anxiety may be at particular risk for depression in the future.

Depression and use of marijuana among US adults
This study examined the association of depression with cannabis use among US adults and the trends for this association from 2005 to 2016.

Maternal depression increases odds of depression in offspring, study shows
Depression in mothers during and after pregnancy increased the odds of depression in offspring during adolescence and adulthood by 70%.

Targeting depression: Researchers ID symptom-specific targets for treatment of depression
For the first time, physician-scientists at Beth Israel Deaconess Medical Center have identified two clusters of depressive symptoms that responded to two distinct neuroanatomical treatment targets in patients who underwent transcranial magnetic brain stimulation (TMS) for treatment of depression.

A biological mechanism for depression
Researchers report that in depressed individuals there are increased amounts of an unmodified structural protein, called tubulin, in lipid rafts compared with non-depressed individuals.

Depression in adults who are overweight or obese
In an analysis of primary care records of 519,513 UK adults who were overweight or obese between 2000-2016 and followed up until 2019, the incidence of new cases of depression was 92 per 10,000 people per year.

Why stress doesn't always cause depression
Rats susceptible to anhedonia, a core symptom of depression, possess more serotonin neurons after being exposed to chronic stress, but the effect can be reversed through amygdala activation, according to new research in JNeurosci.

Which comes first: Smartphone dependency or depression?
New research suggests a person's reliance on his or her smartphone predicts greater loneliness and depressive symptoms, as opposed to the other way around.

Depression breakthrough
Major depressive disorder -- referred to colloquially as the 'black dog' -- has been identified as a genetic cause for 20 distinct diseases, providing vital information to help detect and manage high rates of physical illnesses in people diagnosed with depression.

CPAP provides relief from depression
Researchers have found that continuous positive airway pressure (CPAP) treatment of obstructive sleep apnea (OSA) can improve depression symptoms in patients suffering from cardiovascular diseases.

Read More: Depression News and Depression Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.